Call Us: 1.800.873.5297

By

Mirena MDL Update: Judge Dismisses 31 Cases as Time-Barred

  On January 9, Judge Cathy Seibel, who presides over the Mirena MDL in the Southern District of New York (In re: Mirena® IUD Products Liability Litigation, MDL 2434), granted Bayer’s motion to dismiss 31 cases as time-barred under Louisiana, California, Oklahoma and Ohio law. Judge Seibel ruled that none of these plaintiffs’ claims are […]

By

TVM Lawsuit Update (MDL 2187): Judge Denies C.R. Bard’s Request for New Trial

Judge Joseph Goodwin, who presides over the C.R. Bard MDL pending in the Southern District of West Virginia (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL 2187), has denied C.R. Bard’s motion for a new trial on the basis that the manufacturer was not deprived of a fair trial in a […]

By

Xarelto® Litigation Update: Mass Tort Created in Philadelphia State Court

On January 21, Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas issued an Order transferring Xarelto cases currently on file in Philadelphia state court to the court’s mass tort docket for coordination. The cases will be transferred to the court’s Complex Litigation Center for further management. Plaintiffs allege that Xarelto® was introduced […]

By

FDA Approves New Blood Thinning Medication Savaysa (Edoxaban)

The FDA announced that it has approved Savaysa (edoxaban), an anti-clotting drug manufactured by Tokyo-based Daiichi Sankyo and used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problems. Savaysa has also been approved by the FDA to treat […]

By

Daiichi Sankyo Pays $39 Million to Settle False Claims Act Lawsuit

Law 360 reports that Daiichi Sankyo Inc., a Japanese pharmaceutical giant, has agreed to pay $39 million to the Massachusetts government and state Medicaid problems in order to settle a False Claims Act (FCA) lawsuit alleging that the company paid kickbacks to physicians to encourage prescriptions of the company’s cholesterol and blood pressure medications (U.S. […]

By

JPML Will Hear Motion to Centralize Cases Involving Takata Airbags (MDL 2599) During January Session

On January 29, 2015, a hearing before the Judicial Panel on Multidistrict Litigation (JPML) will take place in Miami, Florida regarding the potential Takata Airbag MDL (In re: Takata Airbag Products Liability Litigation, MDL No. 2599). During this hearing, plaintiffs and defendants will present their arguments to the panel as to whether all federally-filed Takata […]

By

TVM MDL Update (MDL 2187): C.R. Bard Transvaginal Mesh Litigation Moves Forward

On December 17, 2014, Judge Joseph Goodwin, the federal judge overseeing the C.R. Bard Multidistrict Litigation (MDL 2187) in West Virginia, issued an order designating sixty (60) transvaginal mesh (TVM) cases involving the manufacturer C.R. Bard as ‘Miniwave 1’ cases. Per a previous order issued by the Court on December 10, 2014, these cases will […]

By

FDA Requires Black Box Warning for Power Morcellators

The Wall Street Journal reports that the Food and Drug Administration (FDA) has called for an immediate ‘Black Box Warning’ for power morcellators, which is “the strongest caution the agency issues.” William Maisel, deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health, said, “We believe that in the vast […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.